Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
EnGeneIC
EnGeneIC
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
EnGeneIC
Total Funding
$21.1 M
EnGeneIC Summary
Company Summary
Overview
EnGeneIC is a biopharmaceutical company focused on developing its proprietary EDV nanocell platform. It serves for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer.
Type
Private
Status
Active
Founded
2001
HQ
Lane Cove West, AU
|
view all locations
Website
https://engeneic.com/
Cybersecurity rating
Sectors
Healthcare
biotech
oncology
pharma
platform
Homepage
Linkedin
youtube
twitter
Table of Contents
Key People
Locations
Competitors
Key People
Bill Harris,
Chief Financial Officer
David Seaton,
Chief Operating Officer
Will Delaat,
Chairman
Stuart Wardman-Browne,
Board Member
and 6 others
Locations
View all
2 locations detected
Lane Cove West, NSW
HQ
Australia
2/25 Sirius Rd
New York, NY
United States
275 Madison Ave 27th floor
Competitors and Similar Companies
Genelux
Healthcare - Public
SOTIO
Healthcare - Private
Elpis Biopharmaceuticals
Healthcare - Private
Amunix Pharmaceuticals
Healthcare - Subsidiary
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top